Recurrent Tumor-Induced Osteomalacia After Surgical Resection: A Case Report Demonstrating Successful Treatment With Burosumab
Abstract
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome in which a mesenchymal tumor secretes fibroblast growth factor 23 (FGF-23), causing renal phosphate wasting and osteomalacia. A 62-year-old woman was referred to our hospital with a two-year history of progressive muscle weakness and generalized bone pain. The patient was nonambulatory and required a wheelchair for mobility. Laboratory evaluation revealed hypophosphatemia and low serum 1,25-dihydroxyvitamin D levels. Further investigation of the hypophosphatemia demonstrated an elevated fractional excretion of phosphate (FeP) and increased serum FGF-23 levels. Genetic testing was negative. A 68Ga-DOTANOC PET/CT scan identified an infiltrative cervical lesion with increased somatostatin receptor expression. The tumor was surgically resected, after which the patient recovered functional ambulation, and serum phosphate normalized. One year later, the patient reported recurrence of musculoskeletal symptoms. Laboratory findings showed hypophosphatemia with an elevated FeP, raising suspicion of tumor recurrence. A repeat 68Ga-DOTANOC PET/CT scan demonstrated increased somatostatin receptor expression in a right parietal calvarial lesion that was not amenable to surgical resection or radiotherapy. Initiation of burosumab therapy led to the normalization of serum phosphate levels and complete resolution of symptoms. TIO is a rare disorder that is frequently misdiagnosed as osteoporosis, resulting in substantial…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.